Mandate

Vinge advises Saab in connection with the sale of C3 Technologies

July 14, 2011

Vinge has advised Saab in connection with the sale of the entire issued share capital of C3 Technologies. Saab is the company’s majority shareholder and the company itself is a spin-off from Saab which offers 3D-data to the consumer market based on Saab’s 3D map technology. Saab received a purchase price of approximately SEK 1 billion, which resulted in a profit to Saab of approximately SEK 900 million. The transaction is subject to customary competition law approvals.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Johan Larsson, Johan Mattsson, Adam Weissbach and Malin Buch as well as project assistants Ida Norlin and Mikaela Mars. Partners Per Eric Alvsing and Karin Grauers and associates Claes Henriksson and Daniel Järmén provided IP law advice.  

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026